115845-51-7

Basic information

• Product Name: TOLUENE-4-SULFONIC ACID OXETAN-2-YLMETHYL ESTER
• Synonyms: TOLUENE-4-SULFONIC ACID OXETAN-2-YLMETHYL ESTER;oxetan-2-ylMethyl4-Methylbenzenesulfonate;Toluene-4-sulfonic acid o...;2-OxetaneMethanol,2-(4-Methylbenzenesulfonate);2-Oxetanemethanol 4-methylbenzenesulfonate;oxetan-2-ylmethyl 4-methylbenzene-1-sulfonate
• CAS NO: 115845-51-7
• Molecular Formula: C₁₁H₁₄O₄S
• Molecular Weight: 242.29146
• Mol File: 115845-51-7.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 383.817°C at 760 mmHg
• Flash Point: 185.926°C
• Appearance: /
• Density: 1.262
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.539
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TOLUENE-4-SULFONIC ACID OXETAN-2-YLMETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: TOLUENE-4-SULFONIC ACID OXETAN-2-YLMETHYL ESTER(115845-51-7)
• EPA Substance Registry System: TOLUENE-4-SULFONIC ACID OXETAN-2-YLMETHYL ESTER(115845-51-7)

Safety Data

• Hazardous Substances Data: 115845-51-7(Hazardous Substances Data)

Usage

General Description

Toluene-4-Sulfonic Acid Oxetan-2-ylmethyl Ester is a specialty chemical utilized primarily in synthetic organic chemistry. As an ester derivative of toluene-4-sulfonic acid, it is structurally related to toluene, which is commonly used as a solvent and a precursor to various compounds. The presence of an oxetane ring in its structure suggests that it may act as a reactive intermediate or a functional group in synthetic reactions. Its precise applications can vary depending on the specific requirements of the synthesis process. However, details about its toxicity, environmental impact, or precise uses in industry or research are often not extensively documented due to its specialized nature.

InChI:InChI=1/C11H14O4S/c1-9-2-4-11(5-3-9)16(12,13)15-8-10-6-7-14-10/h2-5,10H,6-8H2,1H3

Upstream product

• 61266-70-4 oxetan-2-ylmethanol 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1034354-56-7 5-chloro-N-[(2Z)-5,5-dimethyl-3-(oxetan-2-ylmethyl)-1,3-thiazolidin-2-ylidene]-2-methoxybenzamide 
• 939759-23-6 racemic 2-(bromomethyl)oxetane 
• 121138-00-9 2-(iodomethyl)oxetane 
• 45377-87-5 2-chloromethyloxetane 
• 115845-52-8 2-(4-chlorophenylthiomethyl)oxetane 

Relevant articles and documents

STRAD-BINDING AGENTS AND USES THEREOF

Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

ARYL GLYCOSIDE COMPOUND, PREPARATION METHOD AND USE THEREOF

Disclosed are an aryl glycoside compound as represented by formula I or formular I′, a pharmaceutically acceptable salt thereof, optical isomer thereof or a prodrug thereof. The present invention relates to a method of preparing said aryl glycoside compound and the use thereof The aryl glycoside compound of the present invention has an excellent ability on inhibit SGLT activity, especially SGLT2 activity, and is diabetes-fighting medicine with great potential.